Horizon Kinetics Asset Management LLC Vanda Pharmaceuticals Inc. Transaction History
Horizon Kinetics Asset Management LLC
- $7.14 Billion
- Q4 2024
A detailed history of Horizon Kinetics Asset Management LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 25,912 shares of VNDA stock, worth $115,567. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,912
Previous 24,824
4.38%
Holding current value
$115,567
Previous $116,000
6.9%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VNDA
# of Institutions
155Shares Held
43.7MCall Options Held
33.8KPut Options Held
28.7K-
Black Rock Inc. New York, NY8.14MShares$36.3 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.85MShares$17.2 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$15.6 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.49MShares$11.1 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$10.5 Million0.85% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $252M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...